Crosslinked Alginic Acid Gels Without Copper Cytotoxicity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a demand for novel alginic acid derivatives and crosslinked alginic acid structures that can be safely used in biological applications without copper-derived cytotoxicity, and that offer improved stability and permeability for gel formation.

Innovation Solution

The development of alginic acid derivatives with introduced reactive groups, such as cyclic alkyne and azide groups, allows for crosslinking via a Huisgen reaction at room temperature without a copper catalyst, forming stable crosslinked alginic acid structures that can be chemically and ionically crosslinked, enhancing gel properties and permeability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If a Huisgen reaction is performed using a copper catalyst to crosslink alginic acid, then crosslinking efficiency is improved, but cytotoxicity increases due to copper contamination

Engineering Contradiction:
Improvecrosslinking efficiencyVSAvoidcytotoxicity
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and removes the harmful copper catalyst from the crosslinking system by using copper-free Huisgen reaction conditions, thereby eliminating cytotoxicity while maintaining crosslinking efficiency through alternative reaction pathways

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces an intermediary mechanism by using strain-promoted azide-alkyne cycloaddition where the cyclic alkyne's ring strain energy acts as an internal driving force, replacing the need for copper catalyst mediation and enabling bioorthogonal crosslinking

Inventive Principle:
Principle #24Intermediary (Mediator)

2Strength

If conventional crosslinking methods are used to improve gel strength, then mechanical strength is improved, but gel permeability deteriorates

Engineering Contradiction:
Improvegel strengthVSAvoidpermeability
Core Design Contradiction:
StrengthVSQuantity of substance

Solution Approach 1:

The invention applies local quality by creating heterogeneous crosslinking density within the gel structure, where crosslinks are strategically formed at specific locations to provide mechanical strength while leaving other regions more open to maintain permeability for nutrient and waste transport

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention utilizes porous material principles by forming a crosslinked gel network that maintains controlled porosity, allowing the gel to exhibit both mechanical strength through crosslinks and permeability through interconnected pores that facilitate mass transport

Inventive Principle:
Principle #31Porous materials

3Stability of the object's composition

If alginic acid is crosslinked to improve stability, then chemical stability is improved, but manufacturing complexity increases

Engineering Contradiction:
Improvechemical stabilityVSAvoidmanufacturing complexity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The invention applies self-service by using inherently reactive functional groups (carboxyl groups of alginic acid, azide and alkyne groups of introduced compounds) that spontaneously undergo crosslinking reactions under mild conditions without requiring complex external catalysts or multi-step manufacturing processes

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention utilizes parameter changes by adjusting pH and temperature to optimize the crosslinking reaction conditions, where slight changes in these parameters control the reaction rate and crosslinking extent, simplifying the manufacturing process while achieving stable crosslinked gels

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The novel crosslinked alginic acid structures provide enhanced stability and permeability, are safe for biological use, and can be molded into beads or gels with controlled substance retention, overcoming copper toxicity concerns and improving gel performance.

Implementation Method 1

a crosslinked alginic acid obtained by performing a Huisgen reaction (1,3-dipolar cycloaddition reaction) using an alginic acid derivative of formula (I) and an alginic acid derivative of formula (II)

Methodology Applied
Scientific EffectHuisgen reaction (1,3-dipolar cycloaddition reaction): Chemical Bonding

Implementation Method 2

the novel crosslinked alginic acid structure is highly stable and suitable for gel formation with improved permeability

Methodology Applied
Scientific EffectGel formation: Gel

Data Source

PatentUS12617905B2Crosslinked alginic acid
Publication Date: 2026.05.05 MOCHIDA PHARM CO LTD
  • US12617905B2 patent drawing
  • US12617905B2 patent drawing
  • US12617905B2 patent drawing

AI summary

Provided are novel alginic acid derivatives and a novel crosslinked alginic acid. The alginic acid derivatives are represented by formula (I) and formula (II). The novel crosslinked alginic acid obtained by Huisgen reaction using an alginic acid derivative of formula (I) and an alginic acid derivative of formula (II).